Dermatology · Omaha, NE
NPI
1558686378
Since 2010
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
4242 Farnam St, Suite 360
Omaha, NE, 68131
Phone (402) 552-2555
Groups this clinician bills Medicare through
Medicare paid, 2024
$511K
11,299 services
Medicare patients, 2024
1,544
Average age 74
Drug cost, 2024
$740K
2,886 prescriptions
Company payments, 2025
$3,227
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Melissa D Darling was code 17003 (destruction skin lesion), 4,023 times for 637 patients. In total Melissa D Darling billed 11,299 services in 106 codes, and Medicare paid $511K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 4,023 | 637 | $4.88 | $20K |
| 99213 Office E&M - Established | Office | 1,501 | 1,116 | $55.82 | $84K |
| 17000 Destruction Skin Lesion | Office | 998 | 764 | $31.38 | $31K |
| 88305 Surgical Pathology Examination | Office | 972 | 514 | $55.34 | $54K |
| 17110 Destruction Skin Lesion | Office | 920 | 778 | $64.81 | $60K |
| 99212 Office E&M - Established | Office | 438 | 383 | $33.85 | $15K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 239 | 66 | $0.60 | $143 |
| 17004 Destruction Skin Lesion | Office | 224 | 162 | $115.54 | $26K |
| 11301 Removal or Shaving of Skin Growth | Office | 181 | 134 | $61.29 | $11K |
| 11300 Removal or Shaving of Skin Growth | Office | 129 | 96 | $42.75 | $5,515 |
| 99203 Office E&M - New | Office | 127 | 127 | $64.19 | $8,152 |
| 17311 Mohs Surgery | Office | 100 | 93 | $485.02 | $49K |
| 17111 Destruction Skin Lesion | Office | 99 | 89 | $75.89 | $7,514 |
| 17262 Destruction Skin Lesion | Office | 90 | 65 | $97.33 | $8,760 |
| 17282 Destruction Skin Lesion | Office | 88 | 62 | $132.16 | $12K |
By year: 2022 $564K for 12,391 services; 2023 $551K for 12,308 services; 2024 $511K for 11,299 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 972 | 514 | $55.34 | $54K |
| 88304 Surgical Pathology Examination | 46 | 39 | $32.30 | $1,486 |
| 36415 Venipuncture Blood Collection | 11 | 11 | $7.84 | $86.24 |
Medicare prescription drug claims, 2024
In 2024, the drug Melissa D Darling prescribed most often to Medicare patients was Triamcinolone Acetonide, with 585 prescriptions and refills. In total Melissa D Darling wrote 2,886 Medicare prescriptions that cost $740K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 585 | 672 | 337 | $6,248 |
| Finasteride Generic | 314 | 707 | 94 | $3,376 |
| Minoxidil Generic | 297 | 645 | 87 | $3,517 |
| Clobetasol Propionate Generic | 265 | 295 | 149 | $16K |
| Doxycycline Hyclate Generic | 154 | 177 | 69 | $3,252 |
| Fluconazole Generic | 100 | 190 | 37 | $1,309 |
| Clindamycin Phosphate Generic | 99 | 104 | 60 | $2,206 |
| Ketoconazole Generic | 96 | 102 | 49 | $1,965 |
| Terbinafine Hcl Generic | 82 | 128 | 36 | $738 |
| Cephalexin Generic | 77 | 77 | 66 | $307 |
| Mupirocin Generic | 62 | 62 | 48 | $428 |
| Valacyclovir Valacyclovir Hcl | 61 | 63 | 33 | $1,414 |
| Metronidazole Generic | 57 | 57 | 29 | $3,353 |
| Hydrocortisone Generic | 54 | 60 | 28 | $333 |
| Amoxicillin Generic | 52 | 83 | 14 | $454 |
Brand drugs: 151 claims; generic drugs: 2,735 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Melissa D Darling $3,227 ($3,227 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $496.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 27 | $496 |
| Lilly USA, LLC LLY | 23 | $313 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $286 |
| Genzyme Corporation SNY | 16 | $281 |
| Janssen Biotech, Inc. JNJ | 17 | $271 |
| UCB, Inc. UCB.BR | 19 | $251 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 14 | $236 |
| Pfizer Inc. PFE | 24 | $219 |
| Incyte Corporation INCY | 14 | $180 |
| Amgen Inc. AMGN | 10 | $160 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.